phenobarbital has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verrotti, A | 1 |
| Trotta, D | 1 |
| Di Corcia, G | 1 |
| Blasetti, A | 1 |
| Cutarella, R | 1 |
| Basciani, F | 1 |
| Chiarelli, F | 1 |
1 other study available for phenobarbital and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
[Lafora's disease: one of the causes for drug-resistant epilepsy in adolescence].
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Drug Resistance; Drug Therapy, Combi | 2001 |